Genomic Valley Biotech Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E., 29Th July, 2024

To Considered and approved the standalone Un-Audited financial results of the Company for the quarter ended 30th June, 2024. A copy of the said standalone Un-audited financial results along with the Limited review report from statuary auditor is enclosed herewith.